| Date |
Title |
| 09/30/2008 |
HMG-CoA-reductase inhibitors do not increase incidence of amyotrophic lateral sclerosis (AML) |
| 09/30/2008 |
Epoetin alfa (Eprex) in the Treatment of Acute Ischemic Stroke |
| 09/25/2008 |
Ammonul (sodium phenylacetate and sodium benzoate) Injection – Filter Required |
| 09/19/2008 |
Phosphocol P 32 – Increased Risk of Leukemia and Radiation Injury |
| 09/11/2008 |
Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML) - UPDATE |
| 09/05/2008 |
Tumor Necrosis Factor (TNF) Blocking Agents (adalimumab [Humira], certolizumab pegol [Cimzia], etanercept [Enbrel], infliximab [Remicade])—Risk of Delayed Diagnosis of Opportunistic Infections |
| 08/25/2008 |
Natalizumab (Tysabri) Monotherapy and Progressive Multifocal Leukoencephalopathy |
| 08/21/2008 |
Simvastatin/Ezetimibe (Vytorin) and Increased Risk for Cancer – Ongoing Safety Review |
| 08/20/2008 |
Exenatide (Byetta) and Pancreatitis - Update |
| 08/11/2008 |
Simvastatin products (Zocor, Zetia, Simcor, generic) and Amiodarone (Cordarone, Pacerone, generic) – Potentially Serious Interaction |
| 08/05/2008 |
Actavis Drug Recall |
| 08/01/2008 |
Erythropoiesis-Stimulating Agents (Darbepoetin [Aranesp], Erythropoietin [Epogen, Procrit]) – Proposed Changes in Product Labeling |
| 07/31/2008 |
Dietary Supplements for Erectile Dysfunction – Dangerous Ingredients – UPDATED |
| 07/30/2008 |
Mitoxantrone (Novantrone) – Cardiac Monitoring |
| 07/29/2008 |
Abacavir (Ziagen) and Abacavir-Containing Medications – Patient Screening Recommended |
| 07/25/2008 |
Human Papillomavirus Recombinant Quadrivalent Vaccine, Types 6, 11, 16, 18 (Gardasil®) –Safety Update |
| 07/17/2008 |
Micro-bubble Contrast Agents (Definity and Optison) Associated with Deaths and Serious Cardiopulmonary Reactions UPDATED |
| 07/17/2008 |
Sodium Polystyrene Sulfonate – Recall Due to Contamination with Yeast |
| 07/14/2008 |
Bevacizumab (Avastin®) and sunitinib (Sutent®) – combined use may increase risk of microangiopathic hemolytic anemia |
| 07/11/2008 |
Trastuzumab (Herceptin) and Bacteriostatic Water for Injection Diluent Vials – Potential Vial Damage |
| 07/09/2008 |
Nifedipine (Nifediac™ CC) Extended Release Tablets- Recall |
| 07/09/2008 |
Fluoroquinolones and Tendinitis and Tendon Rupture |
| 07/03/2008 |
Dietary Supplements for Erectile Dysfunction – Dangerous Ingredients – UPDATED |
| 07/02/2008 |
Chlorhexidine Gluconate Skin Preparation Cloth – Recall |
| 07/01/2008 |
Disposal of Prescription Medications in the Community – New Federal Guidelines |
| 06/30/2008 |
Mycophenolate Mofetil (CellCept) and Mycophenolate Acid (Myfortic) and risk of Progressive Multifocal Leukoencephalopathy – Ongoing Safety Review - Updated |
| 06/27/2008 |
Cyclopentolate and Tropicamide Administration Errors |
| 06/16/2008 |
Conventional and Atypical Antipsychotics—Increased Risk of Death in Elderly Patients Taking Antipsychotics for Dementia-Related Psychosis |
| 06/11/2008 |
Morphine Sulfate 60 mg Extended Release Tablets- Recall |
| 06/10/2008 |
Becaplermin Gel (Regranex) and Risk of Cancer Death – Ongoing Safety Review |
| 06/04/2008 |
Anti-Tumor Necrosis Factor (TNF) Agents—Ongoing Safety Review |
| 06/04/2008 |
Calcilo XD Infant Formula – Product Recall |
| 05/30/2008 |
Mommy’s Bliss Nipple Cream – Harmful Ingredients for Nursing Babies |
| 05/30/2008 |
Erectile Dysfunction Dietary Supplements - Dangerous Ingredients — UPDATED |
| 05/21/2008 |
Minocycline (Solodyn) – Two lots recalled due to product mix-up |
| 05/16/2008 |
Mycophenolate Mofetil (Cellcept) and Mycophenolic Acid (Myfortic) and Birth Defect Risk |
| 05/07/2008 |
Alcohol-Free Mouthwash – Recall |
| 05/02/2008 |
Etanercept Black Box Warning of Infection Risk |
| 04/29/2008 |
Actavis Totowa Digoxin (Digitek®) Recall |
| 04/11/2008 |
Mycophenolate Mofetil (CellCept) and Mycophenolate Acid (Myfortic) and risk of Progressive Multifocal Leukoencephalopathy – Ongoing Safety Review |
| 04/11/2008 |
“Total Body Formula” and “Total Body Mega Formula”- High Selenium Concentrations UPDATED |
| 04/10/2008 |
Inhaled Insulin (Exubera) and Lung Cancer |
| 04/10/2008 |
Daptomycin – MBT Contaminant When Stored in ReadyMED Elastomeric Pump |
| 04/10/2008 |
Rotigotine Transdermal Systems Patch |
| 04/03/2008 |
Tegaserod (Zelnorm) – Discontinued, No Longer Available Through Treatment Investigational New Drug Protocol– UPDATE |
| 04/03/2008 |
Heparin – Voluntary Recall of Baxter Heparin Vials, B. Braun Heparin Large Volume Infusion Bags, and Covidien (Kendall) Heparin Flush Prefilled Syringes – Update |
| 04/03/2008 |
Neuraminidase Inhibitors, Oseltamivir Phosphate (Tamiflu) and Zanamivir (Relenza), Associated with Neuropsychiatric Events – Update |
| 03/28/2008 |
Abacavir and Didanosine and Risk of Heart Attack – Ongoing Safety Review |
| 03/28/2008 |
“Total Body Formula” and “Total Body Mega Formula”- Adverse Events Warning |
| 03/27/2008 |
Montelukast (Singulair) and Risk of Behavior Changes, Mood Changes, or Suicidality – Ongoing Safety Review |
| 03/27/2008 |
Becaplermin Gel (Regranex) and Risk of Cancer Death – Ongoing Safety Review |
| 03/26/2008 |
Dietary Supplements for Erectile Dysfunction – Dangerous Ingredients – UPDATED |
| 03/25/2008 |
Sargramostim (Leukine) Liquid Formulation Withdrawn from Market; Special Access Program for Powder Formulation – Update |
| 03/18/2008 |
Disposal of Prescription Medications in the Community – New Federal Guidelines |
| 03/18/2008 |
Tiotropium (Spiriva) and Risk of Stroke – Ongoing Safety Review |
| 03/14/2008 |
Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Epoetin alfa [Epogen, Procrit]) – Revised Black Box Warnings—Update |
| 03/14/2008 |
Darunavir (Prezista)- Hepatotoxicity Warnings |
| 03/11/2008 |
Hydrocodone Long-Acting Antitussives (Tussionex) – Safe Use |
| 03/07/2008 |
Unapproved and Misbranded Drugs for Prevention and Treatment of STDs Marketed over the Internet |
| 03/06/2008 |
Immune Globulin (GamaSTAN S/D™) – Uncalibrated Syringes |
| 03/05/2008 |
Dietary Supplements for Erectile Dysfunction – Dangerous Ingredients – UPDATED |
| 03/04/2008 |
Correct Use of Tiotropium Bromide (Spiriva) and Formoterol Fumarate (Foradil) Capsules |
| 03/04/2008 |
Oseltamivir Phosphate (Tamiflu) and Neuropsychiatric Events – Update |
| 03/04/2008 |
Fentanyl Transdermal System Recall (Actavis, Abrika) - UPDATE |
| 03/04/2008 |
Measles, Mumps, Rubella, and Varicella Vaccine (ProQuad) – Ongoing Safety Review |
| 02/29/2008 |
Heparin – Voluntary Recall of All Baxter Heparin Vials – Update |
| 02/29/2008 |
Natalizumab (Tysabri) – Reports of Liver Injury after Natalizumab Use |
| 02/25/2008 |
Rabies Immune Globulin (HyperRAB S/D) - Uncalibrated Syringes |
| 02/19/2008 |
Fentanyl Transdermal System Recall (Actavis, Abrika) |
| 02/19/2008 |
Fentanyl 25 mcg/hour Transdermal System Recall (Duragesic - Janssen, generic - Sandoz) |
| 02/12/2008 |
Icy Hot Heat Therapy Products - Recall |
| 02/12/2008 |
Botulinum Toxin Types A and B - Safety Review |
| 02/12/2008 |
Heparin - Voluntary Recall of Baxter 1,000 unit/mL, 5,000 unit/mL, and 10,000 unit/mL Multiple-Dose Vials - Update |
| 02/06/2008 |
FDA Bans the Manufacture of Unapproved Injectable Colchicine Products |
| 02/04/2008 |
Neuropsychiatric Warnings and Precautions added to the Prescribing Information of Varenicline (Chantix) |
| 02/04/2008 |
Heparin - Voluntary Recall of Baxter 1000 units/mL Vials - Update |
| 02/04/2008 |
Antiepileptic Drugs and Increased Risk of Suicidal Behavior or Suicidal Ideation |
| 02/01/2008 |
NuCel Labs “Eye Drops” and “Eye/Ear Wash” Recalled |
| 01/25/2008 |
Preliminary Results of Ezetimibe/Simvastatin versus Simvastatin Alone (ENHANCE) |
| 01/25/2008 |
Sargramostim (Leukine) Liquid Formulation Withdrawn from Market; Special Access Program for Powder Formulation |
| 01/23/2008 |
Heparin - Voluntary Recall of Baxter 1000 units/mL Vials |
| 01/23/2008 |
Heparin Lock Flush Pre-filled Syringes and Normal Saline Pre-filled Flush Syringes Recalled by AM2 PAT, Inc. - Update |
| 01/23/2008 |
Ortho Evra® (norelgestromin/ethinyl estradiol) Labeling Update |
| 01/22/2008 |
Edetate Disodium - Sound-Alike Confusion with Edetate Calcium Disodium |
| 01/22/2008 |
Cough and Cold Medications and Infant Deaths |
| 01/11/2008 |
Bioidentical Hormone Replacement Therapy - Misleading Information |
| 01/08/2008 |
Bisphosphonates -Bone, Joint, and Musculoskeletal Pain Reminder |
| 12/24/2007 |
Fentanyl Transdermal Patch (Duragesic, generics) - Cautions About Safe and Appropriate Use |
| 12/21/2007 |
AM2 PAT, Inc. Heparin Lock Flush Solution Recall |
| 12/14/2007 |
Deferasirox (Exjade) - Potentially Fatal Renal, Hepatic, Hematologic, and Allergic Events |
| 12/12/2007 |
Carbamazepine (Tegretol) - Skin Reactions More Common in Patients with Human Leukocyte Antigen B*1502 Allele |
| 12/12/2007 |
Omeprazole (Prilosec/Zegerid/generic) and Esomeprazole (Nexium) - Possible Association with Cardiac Events |
| 12/06/2007 |
Desmopressin - Risk of Hyponatremia and Seizures |
| 11/27/2007 |
Mycophenolate Mofetil (Cellcept, Myfortic) - Pregnancy Risk Category Updated |
| 11/27/2007 |
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients - UPDATED |
| 11/26/2007 |
Varenicline (Chantix) - Ongoing Safety Review |
| 11/20/2007 |
Cefepime (Maxipime) - Ongoing Safety Review |
| 11/15/2007 |
Rosiglitazone (Avandia) - Possible Association with Ischemic Cardiovascular Events - UPDATED |
| 11/13/2007 |
Erythropoiesis-Stimulating Agents (Darbepoetin alfa [Aranesp], Epoetin alfa [Epogen, Procrit]) - Revised Black Box Warnings |
| 11/5/2007 |
Aprotinin (Trasylol) Marketing Temporarily Suspended Pending Ongoing Safety Review - Update |
| 11/2/2007 |
NC Solution, and other Products by General Therapeutics Corp. Seized |
| 10/30/2007 |
Mycophenolate Mofetil (Cellcept) - Pregnancy Risk Category Updated |
| 10/29/2007 |
Aprotinin (Trasylol) - Ongoing Safety Review |
| 10/25/2007 |
Modafanil (Provigil) - Rash and Psychiatric Warnings |
| 10/18/2007 |
Exenatide (Byetta) and Pancreatitis |
| 10/15/2007 |
Micro-bubble Contrast Agents (Definity and Optison) Associated with Deaths and Serious Cardiopulmonary Reactions |
| 10/11/2007 |
Cochlear Implant Device Patient Immunization Alert |
| 10/2/2007 |
Bisphosphonates - FDA Issues Early Communication Regarding Atrial Fibrillation |
| 9/28/2007 |
Gadolinium-Containing Contrast Agents (Omniscan®/OptiMARK®/Magnevist®/ProHance®/MultiHance®) Possible Association With Serious Nephrogenic Fibroses — UPDATE |
| 9/28/2007 |
Hydrocodone Antitussives - FDA Halts Marketing of Unapproved Products |
| 9/28/2007 |
Fentanyl Buccal Tablet (Fentora®) - Inappropriate Use Causes Death/Adverse Effects— UPDATED |
| 9/28/2007 |
Medicaid Tamper-Resistant Requirement - Delayed 6 Months |
| 9/28/2007 |
Baby's Bliss Gripe Water by MOM Enterprises Recalled |
| 9/26/2007 |
Disposal of Prescription Medications in the Community - New Federal Guidelines - UPDATED |
| 9/24/2007 |
Erectile Dysfunction Dietary Supplements - Dangerous Ingredients — UPDATED |
| 9/19/2007 |
B. Braun Normal Saline Flush Recall |
| 9/19/2007 |
Haloperidol - Updated Labeling Regarding Risk of Torsades de Pointes and QT Prolongation |
| 9/14/2007 |
Ceftriaxone Injection (Rocephin) - Interaction with Calcium Products and New Contraindication in Hyperbilirubinemic Neonates — UPDATE |
| 9/14/2007 |
Nelfinavir Mesylate (Viracept) - New Impurity Specifications |
| 9/14/2007 |
Fentanyl Buccal Tablet (Fentora®) - Inappropriate Use Causes Death/Adverse Effects |
| 9/13/2007 |
Abbott Blood Glucose Meter Display Problems |
| 9/7/2007 |
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients — UPDATED |
| 9/7/2007 |
Daytrana™ (Methylphenidate Transdermal System) Recall |
| 8/27/2007 |
National Provider Identifier (NPI) - Personal Information Alert — UPDATED |
| 8/22/2007 |
METABOSLIM Dietary Supplement Contains Undeclared Sibutramine — UPDATED |
| 8/20/2007 |
Cough and Cold Medications and Infant Deaths — UPDATED |
| 8/20/2007 |
Entecavir (Baraclude) and Possible HIV Resistance — UPDATED |
| 8/20/2007 |
Warfarin - Pharmacogenomic Labeling Changes |
| 8/17/2007 |
Codeine use in Nursing Mothers with a Specific Genotype 5/lead to Morphine Overdose in the Nursing Infant |
| 8/16/2007 |
Omacor Brand Name Changed to Lovaza |
| 8/15/2007 |
Lopinavir/Ritonavir Oral Solution (Kaletra) - Potential Risk of Overdose in Children |
| 8/15/2007 |
Rosiglitazone (Avandia) and Pioglitazone (Actos) - Stronger Warnings about Heart Failure |
| 8/14/2007 |
Omeprazole (Prilosec/Zegerid/generic) and Esomeprazole (Nexium) - Possible Association with Cardiac Events |
| 8/14/2007 |
Red Yeast Rice Supplements 5/Contain Lovastatin |
| 8/8/2007 |
Tigecycline Reformulation |
| 8/2/2007 |
Medicaid Tamper-Resistant Requirement |
| 7/31/2007 |
National Provider Identifier (NPI) - Personal Information Alert |
| 7/30/2007 |
Tegaserod (Zelnorm) - Discontinued/Now Available for Restricted Use Under Treatment Investigational New Drug - UPDATE |
| 7/10/2007 |
Ceftriaxone Injection (Rocephin) - Interaction with Calcium Products and New Contraindication in Hyperbilirubinemic Neonates |
| 7/9/2007 |
Ertapenem Sodium (Invanz) Recall |
| 7/5/2007 |
Oxycodone Extended-Release Tablets From Endo, Dava, and Watson - Discontinued |
| 7/3/2007 |
Omalizumab (Xolair) - Reports of Delayed Anaphylaxis — UPDATE |
| 7/2/2007 |
Colistimethate Inhalation Possibly Associated With Death |
| 6/26/2007 |
Rosiglitazone (Avandia) - Possible Association with Ischemic Cardiovascular Events - UPDATED |
| 6/19/2007 |
RotaTeq (Rotavirus/Live/Oral/Pentavalent) vaccine - Reports of Kawasaki disease |
| 6/19/2007 |
Propofol (Diprivan/generics) - Adverse Events Resembling Bacterial Sepsis |
| 5/30/2007 |
Infant Formula with Iron Recall - Abbott Similac Special Care 24 Cal/fl. oz. Ready-to-Feed Premature |
| 5/30/2007 |
Advanced Medical Optics Contact Lens Solution Recall |
| 5/24/2007 |
Rosiglitazone (Avandia) - Possible Association with Ischemic Cardiovascular Events |
| 5/23/2007 |
Deferasirox (Exjade) - Potentially Fatal Renal/Hematologic/and Allergic Events |
| 5/23/2007 |
Gadolinium-Containing Contrast Agents (Omniscan®/OptiMARK®/Magnevist®/ProHance®/MultiHance®) Possible Association With Serious Nephrogenic Fibroses — UPDATE |
| 5/22/2007 |
Caffeine Citrate Powder/Purified - Recall |
| 5/16/2007 |
Disposal of Prescription Medications in the Community - New Federal Guidelines - UPDATED |
| 5/11/2007 |
OxyContin (oxycodone extended-release) manufacturer pleads guilty to misbranding and misrepresenting product |
| 5/11/2007 |
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients - UPDATED |
| 5/7/2007 |
Antidepressants and Suicidality in Adults |
| 5/3/2007 |
Colchicine Injection - Recall of Compounded Product |
| 5/3/2007 |
Counterfeit Medications on the Internet - FDA Warning about Xenical (orlistat) |
| 4/27/2007 |
PharmaFab to Stop Manufacturing Unapproved Drugs |
| 4/24/2007 |
Bevacizumab (Avastin) and Tracheoesophageal Fistula |
| 4/17/2007 |
Disposal of Prescription Medications in the Community - New Federal Guidelines |
| 4/12/2007 |
Tizanidine (Zanaflex) - Contraindicated with Fluvoxamine or Ciprofloxacin |
| 4/12/2007 |
Alglucosidase Alfa (Myozyme) - Formation of Black Particles During Reconstitution |
| 4/12/2007 |
Griseofulvin (Grifulvin V) Oral Suspension - Recall |
| 4/12/2007 |
Ziagen (Abacavir Sulfate) and Combivir (Lamivudine/Zidovudine) - Third Party Tampering |
| 4/9/2007 |
Trimethobenzamide Suppositories - Discontinued Due to Lack of Efficacy |
| 3/30/2007 |
Tegaserod (Zelnorm) - Discontinued |
| 3/30/2007 |
Pergolide Products Withdrawn From Market Due to Heart Valve Damage |
| 3/29/2007 |
Accutane (Isotretinoin) - New Informational FDA web site |
| 3/27/2007 |
Telithromycin (Ketek) Updated Warnings - updated |
| 3/21/2007 |
Erectile Dysfunction Dietary Supplements - Dangerous Ingredients - UPDATED |
| 3/19/2007 |
Linezolid (Zyvox®) - Increased Mortality Following Treatment of Intravascular Catheter-Related Infections |
| 3/15/2007 |
Sedative-Hypnotic Labeling Revisions |
| 3/9/2007 |
Erythropoiesis-Stimulating Agents (Darbepoetin [Aranesp]/Erythropoetin [Epogen/Procrit]) - New Black Box Warnings |
| 3/9/2007 |
Interferon Gamma-1b (Actimmune) - Early Termination of Trial for Idiopathic Pulmonary Fibrosis |
| 3/9/2007 |
Pioglitazone (Actos/Actoplus Met/Duetact) and Rosiglitazone (Avandia/Avandamet/Avandaryl) Increased Fracture Risk - Update |
| 3/7/2007 |
Salivart Oral Moisturizer Recall |
| 3/5/2007 |
Ergotamine – FDA Halts Marketing of Unapproved Products |
| 3/1/2007 |
Entecavir (Baraclude) and Possible HIV Resistance |
| 2/26/2007 |
Mycophenolate Mofetil Plus Sirolimus – Increased Acute Rejection In Cardiac Transplant Patients |
| 2/23/2007 |
Hyperactivity Medications: Patient Medication Guide Required due to Cardiovascular and Psychiatric Adverse Effects |
| 2/22/2007 |
Omalizumab (Xolair) - New Reports of Delayed Anaphylaxis |
| 2/21/2007 |
Internet Medications - Dangerous and Mislabeled Ingredients |
| 2/20/2007 |
Erythropoiesis-Stimulating Agent (Darbepoetin alfa [Aranesp]) Increases Death in Non-Chemotherapy-Induced Anemia - Update |
| 2/20/2007 |
Rotavirus/Live/Oral Pentavalent Vaccine (RotaTeq) - Post-Marketing Reports of Intussusception |
| 2/15/2007 |
Telithromycin (Ketek) Updated Warnings |
| 2/15/2007 |
Oxycodone Extended-Release Tablets From Endo - Discontinued |
| 2/12/2007 |
Topical Anesthetic Agents for Cosmetic Procedures - Potentially Fatal Adverse Effects |
| 2/12/2007 |
Heparin Administration Errors - Use of Incorrect Concentrations |
| 2/2/2007 |
Daptacel (DTaP) and Adacel (Tdap) Administration Errors |
| 2/2/2007 |
Ranibizumab (Lucentis®) 0.5 mg Increases Stroke Risk - UPDATED |
| 1/29/2007 |
Darbepoetin alfa (Aranesp) Increases Death in Non-Chemotherapy-Induced Anemia |
| 1/26/2007 |
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients - UPDATED |
| 1/19/2007 |
Cough and Cold Medications and Infant Deaths |
| 1/10/2007 |
Oseltamivir Phosphate (Tamiflu) and Neuropsychiatric Events — UPDATED |
| 1/2/2007 |
Floranex (Lactobacillus) and Florinef (fludrocortisone) Name Confusion |
| 12/26/2006 |
Gadolinium-Containing Contrast Agents (Omniscan®/OptiMARK®/Magnevist®/ProHance®/MultiHance®) Possible Association With Serious Nephrogenic Fibroses — UPDATE |
| 12/21/2006 |
Rituximab (Rituxan®) and Progressive Multifocal Leukoencephalopathy (PML) |
| 12/19/2006 |
FDA Warns Pharmacies Against Compounding Topical Anesthetic Creams and Other Products |
| 12/18/2006 |
Aprotinin (Trasylol): Increased Risk Of Myocardial Infarction/Stroke/Renal Dysfunction/and Anaphylaxis - Update |
| 12/14/2006 |
Ketamine HCl 10mg/mL Injection - Recall |
| 12/13/2006 |
Quinine Sulfate - FDA Orders Halt of the Sale of Unapproved Products |
| 12/12/2006 |
Heparin -Induced Thrombocytopenia - Delayed-Onset Warning |
| 11/28/2006 |
Methadone Hydrochloride - Cardiac and Respiratory Deaths |
| 11/20/2006 |
Epoetin alfa/Darbepoetin alfa: Hemoglobin Target above 12 g/dL Increases Cardiovascular Risk |
| 11/15/2006 |
Oseltamivir Phosphate (Tamiflu) and Neuropsychiatric Events |
| 11/10/2006 |
Acetaminophen 500 mg Tablets (Store Brands) - Recall |
| 10/30/2006 |
Venlafaxine (Effexor®/Effexor XR®) - Overdose Risk |
| 10/24/2006 |
Meningococcal Conjugate Vaccine Associated with Guillain Barré Syndrome |
| 10/19/2006 |
Imatinib Mesylate (Gleevec®) - Cardiac Events |
| 10/17/2006 |
OneTouch® Blood Glucose Test Strips - Counterfeit Alert |
| 10/16/2006 |
DEA Numbers 5/Begin With Letter "F" |
| 10/12/2006 |
Accutane and Generic Isotretinoin - iPLEDGE Risk Management Program Modification |
| 10/11/2006 |
Warfarin Sodium (Coumadin®) - Patient Medication Guide and Black Box Warning |
| 10/5/2006 |
Increased risk of myocardial infarction/stroke/and renal dysfunction with aprotinin - UPDATED |
| 10/3/2006 |
Lamotrigine (Lamictal) During Pregnancy 5/Increase Risk of Cleft Lip or Cleft Palate |
| 9/27/2006 |
Bevacizumab (Avastin®) and Risk of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) and Nasal Septum Perforation |
| 9/21/2006 |
Ortho Evra Patch 5/Increase Blood Clot Risk |
| 9/14/2006 |
Ibuprofen and Aspirin Drug Interaction |
| 9/7/2006 |
Ephedrine alkaloids in dietary supplements illegal to market in US |
| 9/7/2006 |
Famotidine and Lorazepam Administration Errors |
| 8/22/2006 |
Dextroamphetamine (Dexedrine/Dexedrine Spansule) Labeling Changes/Including Sudden Death |
| 8/21/2006 |
Galactose/Maltose/and Xylose Products/Falsely Elevated Glucose Results With - Update |
| 8/18/2006 |
Hydralazine HCl 20mg/mL Injection - Recall - Update |
| 8/11/2006 |
Compounded Inhalation Solutions 5/Not Be Safe |
| 8/7/2006 |
Lamisil (Terbinafine) and Lamictal (Lamotrigine) Name Confusion |
| 8/2/2006 |
Kaopectate and Generic Kaolin-Pectin Products - Reformulation |
| 8/2/2006 |
Vapor Patch Voluntary Recall - Triaminic Vapor Patch and WellPatch Cough & Cold Soothing Vapor Pads |
| 7/25/2006 |
Iopromide 370 mg/mL Injection (Ultravist) Recall |
| 7/25/2006 |
Bismacine Injection (Chromacine) - Avoid Use for Lyme Disease |
| 7/20/2006 |
SSRI Treatment During Pregnancy |
| 7/20/2006 |
Serotonin Syndrome With Triptans Plus SSRIs or SNRIs |
| 7/18/2006 |
Dietary Supplements for Erectile Dysfunction - Dangerous Ingredients |
| 7/6/2006 |
Tipranavir Associated With Intracranial Hemorrhage |
| 6/30/2006 |
Updated: Telithromycin/Cases of Severe Hepatotoxicity |
| 6/23/2006 |
Triaminic Vapor Patch Voluntary Recall |
| 6/12/2006 |
Gadolinium-Containing Contrast Agents (Omniscan®/OptiMARK®/Magnevist®/ProHance®/MultiHance®) Possible Association With Serious Nephrogenic Fibroses. |
| 6/9/2006 |
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) Associated with Birth Defects in First Trimester |
| 6/6/2006 |
Updated: Natalizumab (Tysabri) - Resumed Marketing With a Special Restricted Distribution Program |
| 5/16/2006 |
Paroxetine (Paxil®/Paxil CR®) Labeling Changes - Suicidality in Adults |
| 5/11/2006 |
Oral Sodium Phosphate Products for Bowel Cleansing - Renal Adverse Effects |
| 5/5/2006 |
Recall of Goldline Brand Extra-Strength Acetaminophen 500 mg (Genapap/Genebs) |
| 4/14/2006 |
Contact Lens Solutions: Fungal Eye Infections in Soft Contact Lens Wearers |
| 4/7/2006 |
Pegaptanib Sodium Injection (Macugen): Labeling Changes Due to Reports of Anaphylaxis and Angioedema |
| 3/31/2006 |
Diazepam Rectal Gel (Diastat Acudial): Applicator Defect 5/Prevent Delivery of Complete Dose. |
| 3/20/2006 |
Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding - UPDATE |
| 3/17/2006 |
Denileukin diftitox (Ontak) 5/Cause Visual Loss |
| 3/14/2006 |
Steroid Products Sold Illegally as Dietary Supplements |
| 3/6/2006 |
Salagen (pilocarpine) and Selegiline (Eldepryl) Name Confusion |
| 3/3/2006 |
Bosentan (Tracleer) 5/Cause Hepatotoxicity |
| 3/2/2006 |
Amicar and Omacor Dispensing Errors |
| 2/24/2006 |
Infant Formula by Gentlease Recalled |
| 2/17/2006 |
Quinolones and Blood Glucose Abnormalities (Hypoglycemia/Hyperglycemia) |
| 2/17/2006 |
Gatifloxacin (Tequin) and Blood Glucose Abnormalities/Contraindicated in Diabetics |
| 2/16/2006 |
Premarin/Prempro/and Premphase |
| 2/15/2006 |
Balanced Salt Solution by Cytosol Labs Recalled |
| 2/15/2006 |
Benzocaine Sprays - Increased Risk of Methemoglobinemia |
| 2/6/2006 |
Increased risk of myocardial infarction/stroke/and renal dysfunction with aprotinin |
| 2/1/2006 |
Nimodipine boxed warning: Do not give parenterally |
| 1/26/2006 |
Hydroxyurea Associated Cutaneous Vasculitic Toxicities |
| 1/24/2006 |
Potential Cancer Risk With Topical Pimecrolimus (Elidel) and Tacrolimus (Protopic) - Updated |
| 1/23/2006 |
ACCU-CHEC glucose meter device recall |
| 1/19/2006 |
Brazilian Diet Pills 5/Contain Chlordiazepoxide/Fluoxetine/or Stimulants |
| 1/19/2006 |
Amantadine and Rimantadine/High Levels of Resistance By Influenza A H3N2 Viruses |
| 1/13/2006 |
Clozapine Labeling Changes - White Blood Cell Count Monitoring Changes |
| 1/12/2006 |
Rho(D) Immune Globulin Intravenous (WinRho) - Hematologic Safety Reports |
| 1/12/2006 |
Rosiglitazone - New Onset or Worsening Macular Edema |
| 1/10/2006 |
Nalbuphine (Nubain) - Use During Labor and Delivery |
| 1/3/2006 |
Fraudulent Avian Flu Therapies - Potentially harmful or 5/interfere with conventional treatments |
| 12/22/2005 |
Oseltamivir (Tamiflu) Supply Status |
| 12/15/2005 |
Methotrexate Injection From Bedford Recalled Due to Ethylene Glycol Content |
| 12/13/2005 |
Clarithromycin (Biaxin/Biaxin XL)- study shows increased cardiovascular mortality |
| 12/8/2005 |
Paxil and Paxil CR - updated Pregnancy Precautions |
| 12/2/2005 |
Epoetin Alfa (Epogen®/Procrit®) and Darbepoetin Alfa (Aranesph®) - Associated with Pure Red Cell Aplasia |
| 12/2/2005 |
MBI Ordered to Cease Manufacturing and Distributing Products |
| 12/2/2005 |
Alemtuzumab (Campath) Associated with Severe Idiopathic Thrombocytopenic Purpura in Multiple Sclerosis Trials |
| 12/2/2005 |
Recombinant Factor VIIa (NovoSeven) - Increased Risk of Arterial Thromboembolic Events |
| 11/28/2005 |
Flu Vaccine Supply Update - 11/28/05 |
| 11/23/2005 |
Tamsulosin (Flomax) Associated with Intraoperative Floppy Iris Syndrome |
| 11/23/2005 |
GenTeal Gel and GenTeal GelDrops Artificial Tears Recall (Novartis Ophthalmics) |
| 11/18/2005 |
Long-Acting Beta 2-Agonists Can Increase Severe Asthma Episodes |
| 11/15/2005 |
Ortho Evra: higher estrogen exposure than oral contraceptives |
| 11/15/2005 |
Alefacept (Amevive) not recommended for HIV patients |
| 11/14/2005 |
Galactose/Maltose/and Xylose Products/Falsely Elevated Glucose Results With |
| 11/10/2005 |
Flu Vaccine Supply Update |
| 11/4/2005 |
Morphine Extended Release (Avinza) - Alcohol 5/cause dose-dumping |
| 11/3/2005 |
Ibritumomab tiuxetan (Zevalin) and Rituximab (Rituxan) - Potentially-fatal Skin and Mucus Membrane Reactions |
| 10/28/2005 |
Pemoline Products Withdrawn from Market due to Risk of Liver Toxicity |
| 10/28/2005 |
Oseltamivir (Tamiflu) Supply Status |
| 10/26/2005 |
Flu Vaccine - Supply Update and Administration Questions |
| 10/18/2005 |
Duloxetine (Cymbalta®) 5/Exacerbate Hepatic Injury in Patients with Preexisting Liver Disease |
| 10/4/2005 |
Guillain Barre Syndrome associated with meningococcal conjugate vaccine |
| 10/3/2005 |
Atomoxetine (Strattera) - Increased Risk of Suicidal Ideation in Pediatric Patients |
| 9/28/2005 |
Paxil and Paxil CR - updated Pregnancy Precautions |
| 9/28/2005 |
Toprol-XL (metoprolol succinate) extended release tablets name confusion |
| 9/16/2005 |
NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection/[rDNA origin]) NovoLog (insulin aspart [rDNA origin] injection) - Change in Packaging to Help Prevent Dispensing Errors |
| 9/15/2005 |
Cetuximab (Erbitux) - Additional Monitoring for Electrolyte Abnormalities and Infusion Reactions |
| 9/9/2005 |
Kaopectate - Reformulation (updated) |
| 9/6/2005 |
Hepatitis B Vaccine Products Stocked in the Pharmacy |
| 9/6/2005 |
Trastuzumab (Herceptin) Increases Risk of Cardiotoxicity |
| 8/17/2005 |
Accutane and Generic Isotretinoin: New risk management program - iPLEDGE |
| 8/4/2005 |
Recall of Perrigo Infant Drops containing Acetaminophen/Dextromethorphan/or Pseudoephedrine |
| 7/20/2005 |
Efalizumab (Raptiva) associated with hemolytic anemia/thrombocytopenia/and serious infection |
| 7/20/2005 |
UPDATE - Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding |
| 7/20/2005 |
New Guidelines For Appropriate Nesiritide Use |
| 7/14/2005 |
Hydromorphone Extended Release (Palladone) withdrawn for safety reasons |
| 7/12/2005 |
Erectile Dysfunction Drugs and Vision Loss |
| 7/12/2005 |
Fentanyl Boxed Warnings |
| 7/7/2005 |
Eli Lilly Discontinuing Humulin U Ultralente/Humulin L Lente/Regular Iletin II/and NPH Iletin II Insulin Products |
| 7/1/2005 |
Antidepressants and Suicidality in Adults to be Evaluated |
| 6/17/2005 |
Gefitinib (Iressa) - shows no survival benefit for non-small cell lung cancer/use discouraged. |
| 6/16/2005 |
COX-2 Selective Inhibitors and NSAIDs - Patient Medication Guide Requirement |
| 6/13/2005 |
Efavirenz (Sustiva) - Pregnancy Risk has Changed to Category D (positive evidence of fetal risk). |
| 6/6/2005 |
Children's Tylenol Meltaways 80 mg/Children's Tylenol SoftChews 80 mg/and Junior Tylenol Meltaways 160 mg - recalled due to confusing packaging and labeling |
| 5/25/2005 |
Dextromethorphan abuse associated with death |
| 5/25/2005 |
Mitoxantrone (Novantrone) - Cardiotoxicity and Secondary Acute Myelogenous Leukemia (AML) in Patients with Multiple Sclerosis |
| 5/25/2005 |
Able Laboratories Inc. - Recalls All Products/Suspends Manufacturing |
| 5/20/2005 |
Nesiritide 5/adversely effect short-term survival and kidney function in patients with decompensated heart failure |
| 5/20/2005 |
Albumin considered safe for use in critically ill patients |
| 5/20/2005 |
Pamidronate and Zoledronic acid - reports of jaw osteonecrosis - UPDATED |
| 4/29/2005 |
Drotrecogin alfa (Xigris) Not Effective in Pediatric Patients with Severe Sepsis |
| 4/25/2005 |
Promethazine (Phenergan) injection classified as vesicant |
| 4/25/2005 |
Oxcarbazepine (Trileptal) 5/cause serious skin and multiorgan hypersensitivity reactions |
| 4/25/2005 |
Interferon beta-1b (Betaseron) 5/cause hepatotoxicity |
| 4/25/2005 |
Galantamine brand name changed to Razadyne |
| 4/12/2005 |
Atypical Antipsychotics - increased mortality in elderly patients with dementia |
| 4/7/2005 |
Adverse Effects of NSAIDs - Valdecoxib withdrawn/labeling changes for all NSAIDs |
| 4/5/2005 |
Galantamine (Reminyl) - possible increased mortality in patients with mild cognitive impairment |
| 3/31/2005 |
Nefazodone 50 mg/100 mg/150 mg/200 mg/and 250 mg Tablets Recall (Ivax Pharmaceuticals) |
| 3/23/2005 |
Changes to CII prescribing - Postdating no longer allowed |
| 3/22/2005 |
Gabapentin 100 mg capsules (Neurontin) - Recall |
| 3/18/2005 |
Xigris 5/increase mortality in single organ dysfunction patients |
| 3/17/2005 |
Interferon beta-1a (Avonex) - Reports of serious hepatic injury |
| 1/24/2006 |
Potential Cancer Risk With Topical Pimecrolimus (Elidel) and Tacrolimus (Protopic) |
| 3/10/2005 |
Bisphosphonate-Induced Renal Dysfunction in Oncology Practice |
| 3/3/2005 |
Rosuvastatin (Crestor) - Myopathy and Rhabdomyolysis in Asian-Americans at 40 mg Dose |
| 3/2/2005 |
Drug Storage Changes - Date All Multidose Vials |
| 2/23/2005 |
Tiagabine (Gabitril) can cause seizures in patients without epilepsy |
| 2/18/2005 |
Promethazine and Fatal Respiratory Depression In Children Under Age 2 - Use Contraindicated |
| 2/17/2005 |
Changes to CII prescribing - FAQ |
| 2/10/2005 |
Methylphenidate hydrochloride 2.5 mg/5 mg/and 10 mg Chewable Tablets (Methylin CT) - Recall Update |
| 2/10/2005 |
Saquinavir (Fortovase/Invirase) plus Ritonavir (ritonavir boosted saquinavir) interacts with rifampin - increased liver toxicity reported |
| 2/10/2005 |
Anagrelide (Agrylin) exposure increased in patients with hepatic impairment/contraindicated in severe hepatic impairment |
| 2/10/2005 |
Name confusion with Zyprexa (olanzapine) and Zyrtec (cetirizine HCl)5/lead to medication errors |
| 2/10/2005 |
Amphetamine/Dextroamphetamine (Adderall/Adderall XR)associated with sudden death/sales suspended on Canadian market |
| 1/20/2005 |
Nevirapine (Viramune®) - Risk factors for liver toxicity |
| 1/20/2005 |
Methylphenidate hydrochloride 5 mg Chewable Tablet (Methylin CT) - Recall |
| 1/20/2005 |
Changes to CII prescribing - Postdating no longer allowed |
| 1/14/2005 |
Aranesp (darbepoetin alfa) and Adverse Effects with Off-Label Dosing |
| 1/13/2005 |
Amiodarone hydrochloride tablets (Cordarone®/generic) - Patient Medication Guide Requirement |
| 1/5/2005 |
Avastin (bevacizumab) increased risk of arterial thromboembolic events - Update |
| 12/22/2004 |
Infliximab (Remicade) associated with hepatotoxicity |
| 12/22/2004 |
Atomoxetine (Strattera) associated with liver toxicity |
| 12/21/2004 |
Naproxen (Aleve/Anaprox/Naprelan/Naprosyn) cardiovascular risk |
| 12/21/2004 |
Celecoxib (Celebrex) cardiovascular risk |
| 12/14/2004 |
Valdecoxib (Bextra®) cardiovascular risk and severe skin reactions |
| 12/1/2004 |
Penicillin G benzathine/Penicillin G procaine (Bicillin C-R) and Penicilln G benzathine (Bicillin L-A) - Inappropriate Use for Syphilis |
| 11/22/2004 |
Medroxyprogesterone acetate injection (Depo-Provera® Contraceptive Injection) associated with bone mineral density loss |
| 11/17/2004 |
Mifepristone (Mifeprex/RU-486) associated with serious infection and bleeding |
| 11/9/2004 |
Adalimumab (Humira) and infections/hypersensitivity/and hematologic reaction |
| 10/15/2004 |
Antidepressants and suicidality in children: FDA requests labeling change |
| 10/15/2004 |
Tumor Necrosis Factor (TNF) α Blocking Agents - Increased Risk of Lymphoma and Other Malignancies |
| 10/11/2004 |
Rituximab and Hepatitis |
| 10/6/2004 |
Levoxyl (levothyroxine) |
| 10/5/2004 |
Influenza Virus Vaccine Injection |
| 10/1/2004 |
Pamidronate and Zoledronic acid - reports of jaw osteonecrosis |
| 9/30/2004 |
Rofecoxib (Vioxx®) withdrawn due to cardiovascular risk |
| 9/27/2004 |
Pantoprazole (Protonix) I.V. glass vial breakage |
| 9/2/2004 |
Shipment of Chiron's Influenza Virus Vaccine (Fluvirin) Delayed |
| 9/1/2004 |
Atypical antipsychotics and hyperglycemia |
| 8/25/2004 |
Infliximab (Remicade) new hematologic side effects warnings |
| 8/19/2004 |
Lantus (insulin glargine [rDNA origin] injection recall Lot 40D024/Lot 40D025/Lot 40D027) |
| 8/17/2004 |
Enoxaparin (Lovenox) adjust dose for severe renal impairment |
| 8/16/2004 |
Avastin (bevacizumab) increased risk of thromboembolic events |
| 8/11/2004 |
Altocor® (lovastatin extended release) withdrawal/replaced by Altoprev® |
| 7/6/2004 |
Antidepressant labeling changes |
| 6/10/2004 |
Ondansetron 8-16 mg/New Preparation Guidelines for |
| 5/14/2004 |
Motrin/Children's chewable |
| 5/12/2004 |
Trazodone interactions with CYP3A4 inhibitors & carbamazepine |
| 5/5/2004 |
Seroquel (quetiapine) 25 mg tablet recall Lot 3446J |
| 4/28/2004 |
Tegaserod Maleate (Zelnorm®) |
| 4/28/2004 |
Kaopectate - Reformulation |
| 4/27/2004 |
Dulcolax Products - not all formulations contain bisacodyl |
| 4/16/2004 |
hormone replacement therapy update |
| 4/6/2004 |
Duragesic Patch Recall UPDATE |
| 4/6/2004 |
Human rabies vaccine (Imovax - Aventis Pasteur) |
| 2/23/2004 |
Duragesic Patch Recall |
| 2/2/2004 |
Viramune (nevirapine) |
| 12/2003 |
Ziprasidone and fluoroquinolones. |
| 12/30/2003 |
Ephedra |
| 11/21/2003 |
Arava (leflunomide) |
| 11/21/2003 |
Ultane (sevoflurane) |
| 10/10/2003 |
Morphine sulfate oral solutions |
| 10/3/2003 |
FD&C Blue No. 1 Toxicity |
| 9/10/2003 |
Orlaam® (levomethadyl hydrochloride acetate) |
| 9/3/2003 |
Actiq lozenges |
| 8/28/2003 |
Zenapax (daclizumab) |
| 7/31/2003 |
Lamivudine/Abacavir and Tenofovir |
| 7/2003 |
norethindrone and ethinyl estradiol tablets (Nortrel) |
| 4/2003 |
risperidone (Risperdal® - Janssen Pharmaceutical/Inc.) |
| 2/25/2003 |
pergolide mesylate (Permax) |
| 2/3/2003 |
Dolasetron (Anzemet) |
| 2/3/2003 |
Granisetron (Kytril) |
| 2/3/2003 |
Ondansetron (Zofran) |
| 1/30/2003 |
OneTouch® Test Strips |
| 1/30/2003 |
SureStep® Test Strips |
| 1/10/2003 |
Premarin/Prempro/and Premphase |
| 11/13/2002 |
Valdecoxib (Bextra) |
| 10/28/2002 |
meningococcal polysaccharide vaccine |
| 10/14/2002 |
medroxyprogesterone acetate & estradiol cypionate injectable suspension (Lunelle™) |
| 10/04/2002 |
mefloquine (Lariam®) |
| 5/20/2002 |
(IGIV) Intravenous Immune Globulin |
| 1/2002 |
droperidol (Inapsine) |
